A Form 4 filed on September 17, 2026, reported that Alexander J. Denner, a director of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), acquired 3,694 shares of Class A Common Stock on September 15, 2026, at no cost under the company's non-employee director compensation policy.
Key Highlights
- Reporting person: Alexander J. Denner, listed as a Director of Ironwood Pharmaceuticals Inc.
- Transaction date: September 15, 2026, with the form filed September 17, 2026.
- Shares acquired: 3,694 shares of Class A Common Stock, acquired (transaction code A) at a price of $0.
- Post-transaction ownership: 327,549 shares of Class A Common Stock held directly following the reported transaction.
- Award basis: Shares were issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, according to the filing.
Director Share Award Details for Alexander J. Denner at Ironwood Pharmaceuticals
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Alexander J. Denner, identified in the filing as a Director of Ironwood Pharmaceuticals Inc., received 3,694 shares of Class A Common Stock on September 15, 2026. The transaction code recorded is "A," indicating an acquisition, and the price per share is listed as $0, reflecting a stock award rather than an open-market purchase.
The filing attributes the award to the company's Second Amended and Restated Non-employee Director Compensation Policy, which the filing states became effective January 1, 2024. Following this transaction, Denner's directly held beneficial ownership in Class A Common Stock stands at 327,549 shares, as reported in the filing. No derivative securities transactions were reported in Table II of the form.
The form was signed by Amir Vitale on September 17, 2026, on behalf of the reporting person. Denner's address is listed as c/o Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, Massachusetts 02110. No amendment date is listed, indicating this is an original filing.
What Was Disclosed
The filing disclosed a September 15, 2026, acquisition of 3,694 shares of Ironwood Pharmaceuticals Class A Common Stock by Director Alexander J. Denner at $0 per share under the company's non-employee director compensation policy, bringing his direct holdings to 327,549 shares.



Please wait processing your request...